Related Experiment Videos
Microsatellite instability in sporadic human breast cancers
T Toyama1, H Iwase, H Yamashita
1Department of Surgery II, Nagoya City University Medical School, Japan. t.toyama@cmews2.med.nagoya-cu.ac.jp
International Journal of Cancer
|November 15, 1996
Summary
Replication error (RER) was detected in 8% of human breast cancer patients, often in early-stage, ER-positive tumors. This microsatellite instability may occur independently of oncogene and tumor-suppressor gene alterations in breast cancer development.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Microsatellite instability, referred to as replication error (RER), is a known hallmark of certain cancers.
- Understanding the role of RER in breast cancer pathogenesis is crucial for identifying potential therapeutic targets and diagnostic markers.
Purpose of the Study:
- To analyze RER in human breast cancer specimens.
- To correlate RER status with clinicopathologic characteristics, including tumor stage and hormone receptor status.
- To investigate the association between RER and the amplification of oncogenes or suppression of tumor-suppressor genes in breast cancer.
Main Methods:
- Analysis of microsatellite instability (RER) at 12 genomic loci across 7 chromosomes in 100 human breast cancer specimens.
- Correlation of RER status with clinicopathologic features.
- Investigation of RER association with oncogene amplification and tumor-suppressor gene suppression in a subset of 42 patients.
Main Results:
- 8% (8 out of 100) of breast cancer patients exhibited RER at one or more chromosomal loci.
- RER-positive patients predominantly had early-stage, estrogen receptor-positive (ER-positive) tumors.
- No significant correlation was found between RER and the amplification of specific oncogenes or the suppression of tumor-suppressor genes.
Conclusions:
- RER appears to be an early event in the development of sporadic human breast cancer, particularly in ER-positive early-stage disease.
- The mechanism driving RER in breast cancer may be independent of the genetic alterations typically associated with multi-step carcinogenesis involving oncogenes and tumor-suppressor genes.